Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Beyondspring Inc.
13G/A
Amendment 3
BYSI · G10830100
|
9.2% |
2/13/2026
Event 12/31/2025
|
|||
| Decheng Capital Management III (Cayman), LLC | 3.5% | ||||
| Decheng Capital China Life Sciences USD Fund III, L.P. | 3.5% | ||||
| Decheng Capital China Life Sciences USD Fund II, L.P. | 3.9% | ||||
| Decheng Capital Management II (Cayman), LLC | 3.9% | ||||
| Decheng Capital Global Healthcare Fund (Master), LP | 1.8% | ||||
| Decheng Capital Global Healthcare GP, LLC | 1.8% | ||||
| Xiangmin Cui | 9.2% | ||||
|
BeyondSpring Inc.
13G/A
Amendment 2
BYSI · G10830100
|
11.2% |
8/14/2025
Event 6/30/2025
|
|||
| Decheng Capital Management III (Cayman), LLC | 4.9% | ||||
| Decheng Capital China Life Sciences USD Fund III, L.P. | 4.9% | ||||
| Decheng Capital China Life Sciences USD Fund II, L.P. | 4.0% | ||||
| Decheng Capital Management II (Cayman), LLC | 4.0% | ||||
| Decheng Capital Global Healthcare Fund (Master), LP | 2.3% | ||||
| Decheng Capital Global Healthcare GP, LLC | 2.3% | ||||
| Xiangmin Cui | 11.2% | ||||